Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kiyotaka Ishijima

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Journal of Ophthalmology

Ophthalmology

2018

English

Related publications

Efficacy and Safety of Switching From Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy

Open Ophthalmology Journal

Ophthalmology

2017

English

Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy

Clinical Ophthalmology

Ophthalmology

2012

English

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost

Open Ophthalmology Journal

Ophthalmology

2016

English

Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension

Clinical Ophthalmology

Ophthalmology

2011

English

Efficiency, Safety, and Patient Preference of Switching From Dorzolamide 1%/Timolol 0.5% to Brinzolamide 1%/Timolol 0.5% While Maintaining the Prostaglandin F2α Analog

Clinical Ophthalmology

Ophthalmology

2015

English

Treatment of Open-Angle Glaucoma and Ocular Hypertension With Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

English

Additive Intraocular Pressure-Lowering Effect of Dorzolamide 1%/Timolol 0.5% Fixed Combination on Prostaglandin Monotherapy in Patients With Normal Tension Glaucoma

Clinical Ophthalmology

Ophthalmology

2011

English

24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy

English

Efficacy of the Travoprost/Timolol Fixed Combination Versus the Concomitant Use of Travoprost 0.004% and Timolol 0.1% Gel Formulation

Clinical Ophthalmology

Ophthalmology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kiyotaka Ishijima

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Related publications

Efficacy and Safety of Switching From Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy

Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost

Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension

Efficiency, Safety, and Patient Preference of Switching From Dorzolamide 1%/Timolol 0.5% to Brinzolamide 1%/Timolol 0.5% While Maintaining the Prostaglandin F2&alpha; Analog

Treatment of Open-Angle Glaucoma and Ocular Hypertension With Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Additive Intraocular Pressure-Lowering Effect of Dorzolamide 1%/Timolol 0.5% Fixed Combination on Prostaglandin Monotherapy in Patients With Normal Tension Glaucoma

24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy

Efficacy of the Travoprost/Timolol Fixed Combination Versus the Concomitant Use of Travoprost 0.004% and Timolol 0.1% Gel Formulation

Efficiency, Safety, and Patient Preference of Switching From Dorzolamide 1%/Timolol 0.5% to Brinzolamide 1%/Timolol 0.5% While Maintaining the Prostaglandin F2α Analog